All In Biotech

Drug Trial Radar · NCT00493974

Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)

Antileukotriene Therapy for COPD Exacerbations

Last checked: Nov 20, 2026Latest source record: Nov 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 119 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

119

Actual

Start

Mar 2007

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Jun 29, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is caused by cigarette smoking or by breathing in other lung irritants, including pollution, dust, or chemicals. The purpose of this study is to evaluate the effectiveness of zileuton, a medication that is used to control asthma symptoms, at reducing the length of a hospital stay for adults who are hospitalized for a COPD exacerbation, or worsening of COPD symptoms.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • ZileutonDrug

    Zyflo tablets, 600 mg, 4 times a day

  • PlaceboDrug

    Placebo 4 x daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Length of Hospital StayTime frame: Measured at Day 30

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama Lung Health Center

    Birmingham, Alabama

  • Veteran's Administration Medical Center

    Birmingham, Alabama

  • LA BioMed at Harbor, University of California

    Los Angeles, California

  • University of California San Francisco-Airway Clinical Research Center

    San Francisco, California

  • Denver Health Medical Center

    Denver, Colorado

  • National Jewish Medical and Research Center

    Denver, Colorado

  • Veteran's Administration Medical Center

    Denver, Colorado

  • University of Maryland Hospital

    Baltimore, Maryland

  • Fallon Clinic

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Veteran's Administration Medical Center

    Boston, Massachusetts

  • Veteran's Administration Medical Center

    Ann Arbor, Michigan

  • University of Michigan Medical Center

    Ann Arbor, Michigan

  • Veteran's Administration Medical Center

    Minneapolis, Minnesota

  • HealthPartners Research Foundation

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Temple University Lung Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Emphysema Research Center

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.